Stakeholder registration form
Stakeholder registration form
Clinical guidelines
Stakeholder involvement
The National Institute for Health and Clinical Excellence wants to involve organisations that represent stakeholders in the development of the guidelines on our work programme.
In the NICE clinical guideline development process, stakeholders are:
- national patient and carer organisations that directly or indirectly represent the interests of people whose care is covered by the guideline (‘patient and carer stakeholders’)
- national organisations that represent the healthcare professionals who provide the services described in the guideline (‘professional stakeholders’)
- companies that manufacture the medicines or devices used in the clinical area covered by the guideline and whose interests may be significantly affected by the guideline (‘commercial stakeholders’)
- providers and commissioners of health services in England, Wales and Northern Ireland
- statutory organisations including the Department of Health, the Welsh Assembly Government, NHS Quality Improvement Scotland, the Healthcare Commission and the National Patient Safety Agency
- research organisations that have done nationally recognised research in the area.
Other individuals or groups can contribute to the guideline via the appropriate national, professional or patient organisation. Before completing this form please read either An overview for Stakeholders, the public and the NHS or if you are from a patient/carer group A guide for patients and carers :contributing to a NICE guideline
Completing the form
This is the form for registering interest in the Clinical Guidelines and Cancer Service Guidance Programme. Please complete the form below by indicating:
1. Contact details - Name one person as the contact.
2. Representation - Indicate whether your organisation primarily represents patient, professional or commercial interests.
3. Interest - Please indicate which topics in the new or past programmes you are interested in by ticking the box and give a very brief description of why your organisation should be considered a stakeholder
Sending the Form
Stakeholders will be accepted at any time during the development process and can participate in all consultation stages. Please consult our website for detailed information on the progress of development and the consultation stages for each topic.
Please complete the form below. Your completed form will be submitted to the Guidelines team. You can expect to hear from the Institute within 28 days. If you have any difficulties completing the form, or require a paper copy, please contact us at guidelines@nice.org.uk.
PLEASE NOTE: Once you have become a registered stakeholder we will write to inform you about each new progamme of guideline topics. Therefore, if you have moved organisations, are no longer the NICE contact for your organisation or simply wish your name to be removed from our database please email guidelines@nice.org.uk with your details.
Contact details
| Title | |
| First name | |
| Surname | |
| Telephone | |
| Fax | |
| Job title |
This organisation represents: (please tick one)
| Patient/carers | Commercial companies |
| Health professionals | Research organisations |
| Private healthcare | NHS Trust |
| Statutory | Health Authority |
| Cochrane Group | Social care |
| Statutory | Health Authority |
| NHS Networks | Both patient/carers and health professionals |
| Organisation Name | |
| Address 1 | |
| Address 2 | |
| Address 3 | |
| City | |
| County | |
| Postcode | |
| Country |
Interest in Clinical Guidelines, Short Clinical Guidelines and Optimal Practice Reviews produced by the Centre for Clinical Practice
|
New programme of Clinical Guidelines – 21st Wave
|
Reasons for your organisation's interest in this guideline
|
|
| Stroke - rehabilitation | ||
| Upper gastrointestinal bleeding | ||
| Venous thomboembolic diseases |
|
New programme of Short Clinical Guidelines – 21st Wave
|
Reasons for your organisation's interest in this guideline
|
|
| Colonoscopic surveillance | ||
| Food allergy in children |
|
Clinical guidelines to be updated*
|
Reasons for your organisation's interest in this guideline
|
|
| Caserean section (update) | ||
| Fertility (update) | ||
| Hypertension (update) | ||
| Type 1 diabetes (update) |
| Short Clinical Guidelines in development on earlier programmes* | Reasons for your organisation's interest in this guideline | |
| Barrett’s oesophagus | ||
| Donor breast milk banks | ||
| Motor neurone disease | ||
| Neuropathic pain in adults |
| Guidelines in development on earlier programmes* |
Reasons for your organisation's interest in this guideline
|
|
| Acute chest pain | ||
| Acute coronary syndromes | ||
| Alcohol dependence | ||
| Alcohol use disorders | ||
| Anxiety (update) | ||
| Anxiety and depression | ||
| Autism in children and adolescents | ||
| Chronic heart failure (update) | ||
| Chronic obstructive pulmonary disease (update) | ||
| Colorectal cancer | ||
| Constipation in children | ||
| Delirium | ||
| Depression - primary and secondary care (update) | ||
| Depression - chronic health problems (update) | ||
| Epilepsy (update) | ||
| Hypertension in pregnancy | ||
| Infection control (update) | ||
| Hip fractures | ||
| Lower urinary tract symptoms in men | ||
| Lung cancer (update) | ||
| Meningococcal disease and meningitis in children and young people | ||
| Metastatic malignant disease of unknown primary origin | ||
| Multiple pregnancy | ||
| Neonatal jaundice | ||
| Nocturnal enuresis in children (bedwetting) | ||
| Osteoporosis | ||
| Ovarian cancer | ||
| Pregnant women with complex social factors | ||
| Psychosis with substance misuse | ||
| Sedation in infants, children and young people | ||
| Self harm | ||
| Stable angina | ||
| Transient loss of consciousness in adults | ||
| Venous thromboembolism - prevention | ||
| When to suspect child maltreatment |